**Question:** Delirium tremens is seen in: DNB 10; NEET 13

**Core Concept:** Delirium tremens (DTs) is a severe form of withdrawal syndrome that primarily affects alcohol-dependent individuals. It is characterized by acute onset of confusion, agitation, hallucinations, and autonomic instability. This condition is a medical emergency and requires prompt medical intervention.

**Why the Correct Answer is Right:** DTs are a consequence of abrupt cessation or significant reduction in alcohol intake in patients who have been chronically dependent on alcohol. The withdrawal process leads to the release of excess neurotransmitters, particularly dopamine, and stimulation of the mesolimbic dopamine pathway. This results in the manifestation of severe neuropsychiatric symptoms, including tremors, agitation, confusion, hallucinations, and autonomic instability.

**Why Each Wrong Option is Incorrect:**

A. **DNB 10**: While DTs primarily affect alcohol-dependent individuals, not all patients with alcohol withdrawal will develop DTs. The risk factors for developing DTs include: rapid reduction in alcohol intake, heavy alcohol consumption, and comorbid medical conditions.

B. **NEET 13**: Although alcohol withdrawal symptoms occur in both DNB 10 and NEET 13 (patients with severe alcohol dependence), the specific condition of DTs is not seen in all patients with alcohol withdrawal. DTs are a subset of alcohol withdrawal syndrome, which may manifest with milder symptoms like tremors, nausea, vomiting, and sleep disturbances.

C. **DNB 10**: DTs are not limited to DNB patients; they can occur in any individual with severe alcohol dependence who abruptly stops or reduces alcohol intake.

D. **NEET 13**: DTs are not exclusive to NEET 13 patients; they can develop in individuals with severe alcohol dependence who cease or significantly reduce alcohol intake.

**Clinical Pearl:**

In clinical practice, it is essential to assess patients with a history of heavy alcohol consumption and abrupt cessation or rapid reduction in alcohol intake for the risk of developing DTs. Medical professionals should monitor these patients closely and manage their withdrawal symptoms appropriately to prevent complications and ensure a safe recovery process.